Contemporary Pediatrics
网页September 24th 2024. The needle-free option to treat type 1 allergic reactions, including anaphylaxis, was approved for adults and children who weigh 66 lbs or more on August 9, 2024. FDA accepts roflumilast's sNDA to treat scalp and body psoriasis in adolescents, adults. By Joshua Fitch, Senior Editor. September 24th 2024.
Guidelines - Contemporary Pediatrics
网页AAP cautions against low-carbohydrate diets for children at risk for diabetes. December 1st 2023. According to the American Academy of Pediatrics (AAP), it is recommended that 45% to 65% of total daily calories come from carbohydrates, though very low-carbohydrate diets allow for 20 to 50 grams per day.
News - Contemporary Pediatrics
网页First-generation antihistamine prescriptions linked to higher seizure risk in children. Joshua Fitch, Senior Editor. September 17th 2024. First-generation antihistamine prescriptions were linked to a 22% higher seizure risk in young children, especially those aged 6 to 24 months, according to recent findings.
Latest Conference Articles - Contemporary Pediatrics
网页March 19th 2024. National Association of Pediatric Nurse Practitioners. Traci Gonzales, MSN, APRN, CPNP-PC, explains her session presented at the 2024 NAPNAP National Conference, highlighting the ability to diagnose and manage uncommon causes of chronic respiratory symptoms.
FDA approves levacetylleucine for the treatment of Niemann-Pick …
网页3 天之前 · The FDA has recently approved levacetylleucine (Aqneursa; IntraBio) for the treatment of neurological symptoms associated with Niemann-Pick disease, type C (NPC), in adults and pediatric patients weighing a minimum of 15 kilograms. 1 NPC is a rare genetic disease that causes neurological symptoms and organ dysfunction.This rare disease is …
Gastroenterology - contemporarypediatrics.com
网页FDA approves dupilumab for eosinophilic esophagitis in children aged 1 to 11 years. Joshua Fitch, Senior Editor. January 25th 2024. The approval makes dupilumab the first and only treatment specifically indicated for eosinophilic esophagitis (EoE) patients aged 1 to 11 years that weigh at least 33 lbs (15 kg).
Weekly review: Contemporary Pediatrics' top stories
网页5 天之前 · Led by Joshua Gowin, PhD, of the University of Colorado Anschutz Medical Campus, the study analyzed children aged 9 to 10 years at baseline and followed up two years later to assess the relationship between parent-reported sleep disturbances and suicidal behaviors. Suicide is a leading cause of death among adolescents, with sleep …
Respiratory - Contemporary Pediatrics
网页September 2nd 2024. Editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, highlights the August 2024 issue of Contemporary Pediatrics.
Contemporary Pediatrics week in review: Updated COVID-19 …
网页2023年10月6日 · Tocilizumab-bavi (Tofidence; Biogen) demonstrated a biosimilarity to tocilizumab (Actemra; Genentech) based on multifaceted clinical and non-clinical data for polyarticular juvenile idiopathic arthritis (PJIA) and systemic juvenile idiopathic arthritis (sJIA) in children aged 2 years and up.
Most-viewed articles on Contemporary Pediatrics from August to …
网页2023年11月3日 · Take a look back at some of the top-performing stories from Contemporary Pediatrics with this review article. Stories featured in this article are re-capped and directly link to our most-viewed articles from August through October 2023.